Investor Sues McKesson Over Opioid Oversight Fines
A shareholder of pharmaceutical company McKesson Corp. filed a derivative suit in Delaware recently saying the company's board failed in its oversight of opioid sales even after incurring millions in fines...To view the full article, register now.
Already a subscriber? Click here to view full article